Skip to content Home / Companies / CGON CGO
CG Oncology, Inc. (CGON) XNAS BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Net insider buying (90d)
Latest CGON Insider Trades
About CG Oncology, Inc. (CGON) CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
Headquarters DALLAS, TX
Employees 142
Listed 2024
Exchange XNAS https://www.cgoncology.com SEC filings for CGON on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market purchase 1 371,085 $24.81M Open-market sale 5 36,165 $2.64M Option exercise 10 72,330
CGON Insider Transactions (Form 4) 79 53 Form 4 filings on record, the earliest from Oct 7, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 14, 2026 LP Leonard E. Post - Director Option exercise Common Stock 1,000
Recent CGON Form 8-K Filings 5
Recent CGON Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Sep 11, 2026 AMBAW BELLETE Officer 826 $62K View on EDGAR Sep 2, 2026 AMBAW BELLETE Officer
CGON Insider Trading - FAQ
What is the latest insider trade for CGON? CG Oncology, Inc. (CGON) had 6 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for CGON runs to 53 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying CGON stock? 1 insider purchase of CGON was filed in the last 90 days, totaling $24.81M.
How many insiders are selling CGON stock? 5 insider sales of CGON were filed in the last 90 days, totaling $2.64M.
Where can I see CGON SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks CGON Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow CGON insider buys? Create a free InsiderAlpha account and press Watch on this page to add CGON to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track CGON insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $6.57B
P/E ratio -
Dividend yield -
Average volume 926.7K
52 week high $80.97
52 week low $35.64
Today's high $76.50
Today's low $74.43
Open $75.00
Volume 290.7K
Previous close $74.12
Shares outstanding 88.64M Market cap
$6.57B
142 employees
CGON Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
90% Buying 10% Selling
1 insider purchase totaling $24.81M against 5 sales totaling $2.64M.
Most-Active CGON Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 14, 2026 LP Leonard E. Post - Director Open-market sale Common Stock 1,000 $74.54 $75K
Aug 14, 2026 LP Leonard E. Post - Director Option exercise Director Stock Option (right to buy) 1,000 $0.00 -
Jul 15, 2026 LP Leonard E. Post Option exercise Director Stock Option (right to buy) 1,000 $0.00 -
Jul 10, 2026 JM James Mulay Option exercise Common Stock 24,165 $26.63 $644K
Jul 10, 2026 JM James Mulay Open-market sale Common Stock 24,165 $75.16 $1.82M
Jul 10, 2026 JM James Mulay Option exercise Director Stock Option (right to buy) 24,165 $0.00 -
Jun 24, 2026 LP Leonard E. Post Option exercise Director Stock Option (right to buy) 5,000 $0.00 -
Jun 22, 2026 LP Leonard E. Post Option exercise Director Stock Option (right to buy) 5,000 $0.00 -
Jun 15, 2026 JM James Mulay Open-market sale Common Stock 1,310 $60.12 $79K
Jun 15, 2026 JM James Mulay Option exercise Common Stock 654 $3.72 $2K
Jun 15, 2026 JM James Mulay Option exercise Common Stock 1,310 $12.59 $16K
Jun 15, 2026 JM James Mulay Open-market sale Common Stock 654 $60.12 $39K
Jun 15, 2026 JM James Mulay Option exercise Director Stock Option (right to buy) 654 $0.00 -
Jun 15, 2026 JM James Mulay Option exercise Director Stock Option (right to buy) 1,310 $0.00 -
Jun 4, 2026 JM James Mulay Grant or award Director Stock Option (right to buy) 9,354 $0.00 -
Jun 4, 2026 CR Christina Rossi Grant or award Director Stock Option (right to buy) 9,354 $0.00 -
Jun 4, 2026 LP Leonard E. Post Option exercise Director Stock Option (right to buy) 1,000 $0.00 -
Jun 4, 2026 LP Leonard E. Post Grant or award Director Stock Option (right to buy) 9,354 $0.00 -
Jun 4, 2026 SG Susan E. Graf Grant or award Director Stock Option (right to buy) 9,354 $0.00 -
Apr 17, 2026 JM James Mulay Option exercise Common Stock 15,600 $36.63 $571K
Apr 17, 2026 JM James Mulay Open-market sale Common Stock 15,600 $73.01 $1.14M
Apr 17, 2026 JM James Mulay Option exercise Director Stock Option (right to buy) 15,600 $0.00 -
Apr 15, 2026 AB Ambaw Bellete - Officer Grant or award Employee Stock Option (Right to Buy) 107,508 $0.00 -
Apr 15, 2026 VK Vijay Kasturi - Officer Grant or award Employee Stock Option (Right to Buy) 79,216 $0.00 -
Apr 15, 2026 JP Joshua F. Patterson - Officer Grant or award Employee Stock Option (Right to Buy) 45,266 $0.00 -
Apr 15, 2026 JD James M. Detore - Officer Grant or award Employee Stock Option (Right to Buy) 90,574 $0.00 -
Apr 15, 2026 AK Arthur Kuan - Officer Grant or award Employee Stock Option (Right to Buy) 271,600 $0.00 -
Mar 16, 2026 JM James Mulay Option exercise Common Stock 654 $3.72 $2K
Mar 16, 2026 JM James Mulay Option exercise Common Stock 1,310 $12.59 $16K
Mar 16, 2026 JM James Mulay Option exercise Director Stock Option (right to buy) 1,310 $0.00 -
Mar 16, 2026 JM James Mulay Open-market sale Common Stock 654 $63.50 $42K
Mar 16, 2026 JM James Mulay Open-market sale Common Stock 1,310 $63.50 $83K
Mar 16, 2026 JM James Mulay Option exercise Director Stock Option (right to buy) 654 $0.00 -
Mar 12, 2026 AK Arthur Kuan - Officer Option exercise Employee Stock Option (Right to Buy) 64,612 $0.00 -
Mar 12, 2026 AK Arthur Kuan - Officer Option exercise Common Stock 64,612 $1.72 $111K
Mar 12, 2026 AK Arthur Kuan - Officer Tax withholding / forfeiture Common Stock 1,847 $60.15 $111K
Mar 4, 2026 AK Arthur Kuan - Officer Option exercise Common Stock 102,871 $1.72 $177K
Mar 4, 2026 AK Arthur Kuan - Officer Tax withholding / forfeiture Common Stock 2,871 $61.61 $177K
Mar 4, 2026 AK Arthur Kuan - Officer Option exercise Employee Stock Option (Right to Buy) 102,871 $0.00 -
Jan 9, 2026 JM James Mulay Option exercise Common Stock 654 $3.72 $2K
Jan 9, 2026 JM James Mulay Option exercise Common Stock 10,491 $12.59 $132K
Jan 9, 2026 JM James Mulay Open-market sale Common Stock 654 $44.16 $29K
Jan 9, 2026 JM James Mulay Open-market sale Common Stock 10,491 $52.99 $556K
Jan 9, 2026 JM James Mulay Option exercise Director Stock Option (right to buy) 654 $0.00 -
Jan 9, 2026 JM James Mulay Option exercise Director Stock Option (right to buy) 10,491 $0.00 -
Nov 24, 2025 CR Christina Rossi Grant or award Director Stock Option (right to buy) 20,889 $0.00 -
Nov 17, 2025 LP Leonard E. Post Option exercise Director Stock Option (right to buy) 1,000 $0.00 -
Oct 13, 2025 LP Leonard E. Post Option exercise Director Stock Option (right to buy) 1,000 $0.00 -
Oct 9, 2025 JM James Mulay Option exercise Common Stock 5,903 $3.72 $22K
Oct 9, 2025 JM James Mulay Open-market sale Common Stock 5,903 $43.99 $260K
Oct 9, 2025 JM James Mulay Option exercise Director Stock Option (right to buy) 5,903 $0.00 -
Sep 30, 2025 LP Leonard E. Post Option exercise Director Stock Option (right to buy) 5,000 $0.00 -
Sep 29, 2025 JM James Mulay Option exercise Common Stock 12,755 $1.82 $23K
Sep 29, 2025 JM James Mulay Open-market sale Common Stock 12,755 $39.19 $500K
Sep 29, 2025 JM James Mulay Option exercise Director Stock Option (right to buy) 12,755 $0.00 -
Sep 18, 2025 JM James Mulay Option exercise Common Stock 19,112 $1.82 $35K
Sep 18, 2025 JM James Mulay Open-market sale Common Stock 19,112 $39.01 $746K
Sep 19, 2025 JM James Mulay Option exercise Common Stock 3,574 $1.82 $7K
Sep 19, 2025 JM James Mulay Open-market sale Common Stock 3,574 $38.99 $139K
Sep 18, 2025 JM James Mulay Option exercise Director Stock Option (right to buy) 19,112 $0.00 -
Sep 19, 2025 JM James Mulay Option exercise Director Stock Option (right to buy) 3,574 $0.00 -
$CLDI
Calidi Biotherapeutics, Inc.
